Flaxseed in lupus nephritis: A two-year nonplacebo-controlled crossover study

被引:41
作者
Clark, WF [1 ]
Kortas, C [1 ]
Heidenheim, AP [1 ]
Garland, J [1 ]
Spanner, E [1 ]
Parbtani, A [1 ]
机构
[1] Univ Western Ontario, London Hlth Sci Ctr, London, ON N6A 4G5, Canada
关键词
systemic lupus erythematosus; lupus nephritis; flaxseed; renal outcomes; adherence;
D O I
10.1080/07315724.2001.10719026
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: The objective of this study was to determine the renoprotective effects of ground flaxseed in patients with lupus nephritis. Methods: Forty patients with lupus nephritis were asked to participate in a randomized crossover trial of flaxseed. Twenty-three agreed and were randomized to receive 30 grams of ground flaxseed daily or control (no placebo) for one year, followed by a twelve-week washout period and the reverse treatment for one year. At baseline and sis month intervals, serum phospholipids, flaxseed sachet counts, serum creatinine, 12-hour urine albumin excretion and urine albumin to creatinine ration, serum viscosity and plasma lipids were measured. Results: There were eight drop-outs and of the 15 remaining subjects flaxseed sachet count and serum phospholipid levels indicated only nine were adherent to the flaxseed diet. Plasma lipids and serum viscosity were unaltered by the flaxseed supplementation whereas serum creatinine in the compliant patients during flaxseed administration declined from a mean of 0.97+/-0.31 mg/dL to a mean of 0.94+/-0.30 mg/dL and rose in the control phase to a mean of 1.03+/-0.28 mg/dL [ p value <0.08 ]. Of the fifteen patients mho completed the study, similar changes were noted [ p value <0.1 ]. The nine compliant patients had lower serum creatinines at the end of the two-year study than the 17 patients who refused to participate [ p<0.05 ]. Microalbumin at baseline declined in both control and flaxseed time periods, but there was a trend for a greater decline during flaxseed administration [ p<0.2 ]. Conclusions: Flaxseed appears to be renoprotective in lupus nephritis, but this interpretation is affected by under powering due to poor adherence and potential Hawthorne effects.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 31 条
[1]   DOES CORTICOSTEROID-THERAPY AFFECT THE SURVIVAL OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALBERT, DA ;
HADLER, NM ;
ROPES, MW .
ARTHRITIS AND RHEUMATISM, 1979, 22 (09) :945-953
[2]   PLATELET-ACTIVATING-FACTOR RECEPTOR BLOCKADE AMELIORATES MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BALDI, E ;
EMANCIPATOR, SN ;
HASSAN, MO ;
DUNN, MJ ;
HANZMANN, E .
KIDNEY INTERNATIONAL, 1990, 38 (06) :1030-1038
[3]   LUPUS NEPHRITIS [J].
BALOW, JE ;
AUSTIN, HA ;
TSOKOS, GC ;
ANTONOVYCH, TT ;
STEINBERG, AD ;
KLIPPEL, JH .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (01) :79-94
[4]   PLATELET-ACTIVATING FACTOR-INDUCED LOSS OF GLOMERULAR ANIONIC CHARGES [J].
CAMUSSI, G ;
TETTA, C ;
CODA, R ;
SEGOLONI, GP ;
VERCELLONE, A .
KIDNEY INTERNATIONAL, 1984, 25 (01) :73-81
[5]   FLAXSEED - A POTENTIAL TREATMENT FOR LUPUS NEPHRITIS [J].
CLARK, WF ;
PARBTANI, A ;
HUFF, MW ;
SPANNER, E ;
DESALIS, H ;
CHINYEE, I ;
PHILBRICK, DJ ;
HOLUB, BJ .
KIDNEY INTERNATIONAL, 1995, 48 (02) :475-480
[6]   OMEGA-3 FATTY-ACID DIETARY SUPPLEMENTATION IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CLARK, WF ;
PARBTANI, A ;
HUFF, MW ;
REID, B ;
HOLUB, BJ ;
FALARDEAU, P .
KIDNEY INTERNATIONAL, 1989, 36 (04) :653-660
[7]   FISH-OIL IN LUPUS NEPHRITIS - CLINICAL FINDINGS AND METHODOLOGICAL IMPLICATIONS [J].
CLARK, WF ;
PARBTANI, A ;
NAYLOR, CD ;
LEVINTON, CM ;
MUIRHEAD, N ;
SPANNER, E ;
HUFF, MW ;
PHILBRICK, DJ ;
HOLUB, BJ .
KIDNEY INTERNATIONAL, 1993, 44 (01) :75-86
[8]   WHY DO PATIENTS WITH LUPUS NEPHRITIS DIE [J].
CORREIA, P ;
CAMERON, JS ;
LIAN, JD ;
HICKS, J ;
OGG, CS ;
WILLIAMS, DG ;
CHANTLER, C ;
HAYCOCK, DG .
BMJ-BRITISH MEDICAL JOURNAL, 1985, 290 (6462) :126-131
[9]   NUTRITIONAL ATTRIBUTES OF TRADITIONAL FLAXSEED IN HEALTHY-YOUNG ADULTS [J].
CUNNANE, SC ;
HAMADEH, MJ ;
LIEDE, AC ;
THOMPSON, LU ;
WOLEVER, TMS ;
JENKINS, DJA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 61 (01) :62-68
[10]  
DUBOIS EL, 1974, JAMA-J AM MED ASSOC, V227, P1399